Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $2.85 is 56.59% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 2.94||$ 5.14|
|Low:||$ 2.72||$ 1.82|
Company Description (as filed with the SEC)
We are a pharmaceutical company focused on leveraging our extensive development and oncology expertise to identify and advance new therapies intended to meaningfully improve the treatment of cancer. Our portfolio of drug candidates contains four clinical-stage candidates, including one candidate in an ongoing Phase 3 global registration trial and another candidate that is anticipated to advance, in the fourth calendar quarter of calendar year 2018, into a Phase 2 clinical trial that we intend to submit to the U.S. Food and Drug Administration ("FDA") as support for accelerated approval of a marketing application. Our common stock is listed on the NASDAQ Capital Market under the symbol "MEIP". Our Strategy Our focus is on developing and commercializing cancer treatments intended to effectively leverage the potential of a mechanism of action to provide increased benefit to patients. ... More ...
Nasdaq Official Price
Feb. 21, 2019